Effect of vitamin D in treatment of gestational diabetes
Phase 2
- Conditions
- Gestational diabetes mellitus.Diabetes mellitus in pregnancy, unspecifiedO24.9
- Registration Number
- IRCT201305115623N7
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 54
Inclusion Criteria
Pregnant women aged 18-40 years
Women diagnosed with Gestational Diabetes Mellitus
24-28 weeks' gestation
Exclusion Criteria
Premature preterm rupture of membrane
Placenta abruption
Preeclampsia
Those who required commencing insulin therapy during intervention
Those with hypothyroidism
Urinary tract infection
Smoking
Those with kidney or liver diseases
Those taking estrogen therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25-hydroxyvitamin D. Timepoint: Baseline and End-of-trial. Method of measurement: ELISA kit.;Newborn's lengt. Timepoint: Delivery time. Method of measurement: Tape.
- Secondary Outcome Measures
Name Time Method